Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3929691rdf:typepubmed:Citationlld:pubmed
pubmed-article:3929691lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:3929691lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3929691lifeskim:mentionsumls-concept:C0497093lld:lifeskim
pubmed-article:3929691lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3929691lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:3929691pubmed:issue9lld:pubmed
pubmed-article:3929691pubmed:dateCreated1985-10-7lld:pubmed
pubmed-article:3929691pubmed:abstractTextComparative studies between the in vitro human tumor clonogenic assay (HTCA) and our original in vivo method (NM-IA) in which the final evaluation was made with 3H-TdR incorporation of tumor cells transplanted into nude mice were simultaneously performed on 44 fresh human solid tumors (22 gastric cancers, 6 breast cancers, 4 gall bladder cancers, 4 liposarcomas and 8 other tumors). Mitomycin C (MMC), 5-fluorouracil (5-FU), adriamycin (ADM) and cyclophosphamide (CPM) were tested. The evaluable rate was 73% (32/44) in HTCA and 89% (38/44) in NM-IA. Although correlation between the results of HTCA and those of MN-IA was obtained for MMC and ADM, no correlation was observed for 5-FU and CPM.lld:pubmed
pubmed-article:3929691pubmed:languagejpnlld:pubmed
pubmed-article:3929691pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:citationSubsetIMlld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3929691pubmed:statusMEDLINElld:pubmed
pubmed-article:3929691pubmed:monthSeplld:pubmed
pubmed-article:3929691pubmed:issn0385-0684lld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:HattoriTTlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:NosohYYlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:YamaguchiMMlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:NiimotoMMlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:NishiyamaMMlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:HirabayashiNNlld:pubmed
pubmed-article:3929691pubmed:authorpubmed-author:YoshinakaKKlld:pubmed
pubmed-article:3929691pubmed:issnTypePrintlld:pubmed
pubmed-article:3929691pubmed:volume12lld:pubmed
pubmed-article:3929691pubmed:ownerNLMlld:pubmed
pubmed-article:3929691pubmed:authorsCompleteYlld:pubmed
pubmed-article:3929691pubmed:pagination1808-12lld:pubmed
pubmed-article:3929691pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:meshHeadingpubmed-meshheading:3929691-...lld:pubmed
pubmed-article:3929691pubmed:year1985lld:pubmed
pubmed-article:3929691pubmed:articleTitle[Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].lld:pubmed
pubmed-article:3929691pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3929691pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3929691pubmed:publicationTypeEnglish Abstractlld:pubmed